MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAYLOR, P.
Right arrow Articles by JACOBS, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAYLOR, P.
Right arrow Articles by JACOBS, N. M.

Molecular Pharmacology, Vol 10, 78-92, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

Acetylcholinesterase from Torpedo: Characterization of an Enzyme Species Isolated by Lytic Procedures

PALMER TAYLOR 1, JONATHAN W. JONES 1, and NORMAN M. JACOBS 1

1 Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92037

An acetylcholinesterase has been purified from Torpedo californica by mild proteolysis of electroplax membranes with trypsin (5 µg/ml for 5 min) to solubilize the enzyme, followed by affinity chromatography of the soluble enzyme. The procedure yields an apparently homogeneous enzyme whose molecular weight (approximately 335,000), frictional coefficient (1.65), and amino acid composition all distinguished the Torpedo acetylcholinesterase from that which has been prepared by lytic procedures from Electrophorus. The enzyme is composed of four similar, if not identical, subunits, each of which possesses a catalytic and inhibitor binding site. Torpedo acetylcholinesterase contains 7.9% carbohydrate present as hexoses, hexosamines, and sialic acid, and at least some of these residues are exposed on the outer surface of the molecule. Concanavalin A, a plant lectin with specificity toward mannose residues at nonreducing positions, forms a sedimentable complex with the purified acetylcholinesterase which can be partially reversed by agr-methyl-D-mannoside. Addition of concanavalin A to electroplax membranes markedly inhibits trypsin-induced acetylcholinesterase release from the membrane surface.

Note:
ACKNOWLEDGMENTS We wish to thank Drs. Susan Taylor and Johannes Everse of the Department of Chemistry, University of California, San Diego, for their assistance with the amino acid and sedimentation analyses.

Submitted on June 27, 1973




This article has been cited by other articles:


Home page
Biophys. JHome page
R. H. Meltzer, E. Thompson, K. V. Soman, X.-Z. Song, J. O. Ebalunode, T. G. Wensel, J. M. Briggs, and S. E. Pedersen
Electrostatic Steering at Acetylcholine Binding Sites
Biophys. J., August 15, 2006; 91(4): 1302 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Boyd, C. S. Dunlop, L. Wong, Z. Radic, P. Taylor, and D. A. Johnson
Nanosecond Dynamics of Acetylcholinesterase Near the Active Center Gorge
J. Biol. Chem., June 18, 2004; 279(25): 26612 - 26618.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Bourne, J. Grassi, P. E. Bougis, and P. Marchot
Conformational Flexibility of the Acetylcholinesterase Tetramer Suggested by X-ray Crystallography
J. Biol. Chem., October 22, 1999; 274(43): 30370 - 30376.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics